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Background: Chronic kidney disease (CKD) is associated with cardiovascular (CVS) events due to advanced atherosclerosis. Computed 
tomography coronary angiography (CTA) can accurately diagnose coronary artery disease (CAD) and predict CVS outcomes. However, the impact of 
CKD on risk stratification in patients referred to CTA has not been investigated. The aim of the current study was to evaluate whether the presence of 
moderate CKD can provide additional prognostic information for CVS events in patients undergoing CTA.
Methods: A total of 885 patients underwent CTA. Patients were stratified as having moderate CKD (85 patients) or no CKD (770 patients) based 
on a cut-off value of 60ml/min/1.73m2 estimated glomerular filtration rate derived by the Modified Diet in Renal Disease equation. On CTA, the 
presence of obstructive (≥50% stenosis) CAD was determined. Patients were followed for a median duration of 896±353 days for the occurrence of 
CVS events (non-fatal myocardial infarction, cerebrovascular accident and all-cause mortality).
Results: Patients with moderate CKD had a higher incidence of obstructive CAD compared to those without CKD (47 vs. 32%, p<0.01). A total of 
42 patients experienced an event: the annualized CVS event rate was 1.2% in patients with no CKD and no CAD, 2.5% in patients with moderate 
CKD alone, 2.5% in patients with obstructive CAD alone and 3.7% in those with both moderate CKD and obstructive CAD. Multivariate models 
demonstrated that both moderate CKD (Hazard Ratio [HR] 2.39, Confidence Interval [CI] 1.08-5.26, p=0.03) and obstructive CAD (HR 2.75, CI 
1.38-5.49, p<0.01) were independent predictors of CVS events after adjusting for age, gender and conventional CVS risk factors. Importantly, the 
presence of moderate CKD provided incremental prognostic information in addition to age, gender, CVS risk factors and obstructive CAD (2 = 49.4, 
difference from baseline 3.9, p=0.04).
Conclusion: The present study confirmed the high incidence of obstructive CAD by CTA in patients with moderate CKD. In addition, moderate CKD 
was associated with CVS events and provided incremental prognostic information over age, gender, CVS risk factors and the presence of obstructive 
CAD on CTA.
